Picture of Kimia Biosciences logo

530313 — Kimia Biosciences Cashflow Statement

0.000.00%
in flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Annual cashflow statement for Kimia Biosciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

2022
March 31st
2023
March 31st
2024
March 31st
2025
March 31st
2026
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IAS
IAS
IAS
IAS
IAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-50.2-124-71.813684.6
Depreciation
Non-Cash Items30.142.744.634.533.3
Unusual Items
Other Non-Cash Items
Changes in Working Capital38.2-19.81408.55-48.6
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Accrued Expenses
Other Operating Cash Flow
Cash from Operating Activities47.5-67.7145213108
Capital Expenditures-35.8-28.1-15.1-46-81.6
Purchase of Fixed Assets
Other Investing Cash Flow Items28.70.1340.135-1.020.714
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-7.1-28-14.9-47-80.9
Financing Cash Flow Items-33.5-27.6-35.5-57.2-47
Other Financing Cash Flow
Net Issuance / Retirement of Debt
Cash from Financing Activities-44.395.4-131-166-26.4
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-3.82-0.272-0.3010.5851.12